scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/J.SCHRES.2005.05.027 |
P698 | PubMed publication ID | 16005613 |
P50 | author | Mary Cannon | Q18719324 |
P2093 | author name string | Mary Catherine Clarke | |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 5-13 | |
P577 | publication date | 2005-11-01 | |
P1433 | published in | Schizophrenia Research | Q7431607 |
P1476 | title | Risk for schizophrenia--broadening the concepts, pushing back the boundaries | |
P478 | volume | 79 |
Q37980010 | An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. |
Q42872711 | Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate. |
Q37001100 | Childhood trauma and psychotic disorders: a systematic, critical review of the evidence. |
Q37319453 | Childhood trauma, PTSD, and psychosis: Findings from a highly traumatized, minority sample. |
Q30477667 | Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood |
Q37304289 | Decanalization mediating gene-environment interactions in schizophrenia and other psychiatric disorders with neurodevelopmental etiology. |
Q48263254 | Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development |
Q24652697 | Epigenetic mediation of environmental influences in major psychotic disorders |
Q37180961 | Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort |
Q30477639 | Evaluation of developmental neurotoxicity: some important issues focused on neurobehavioral development |
Q33773196 | Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia |
Q30447546 | Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia |
Q24643775 | Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions |
Q34407170 | Identifying novel interventional strategies for psychiatric disorders: integrating genomics, 'enviromics' and gene-environment interactions in valid preclinical models. |
Q35390447 | Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies. |
Q36287179 | Maladaptive schemas as a mediator between social defeat and positive symptoms in young people at clinical high risk for psychosis |
Q36148572 | Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. |
Q47587674 | Negative symptoms of psychosis: A life course approach and implications for prevention and treatment |
Q22252797 | Neighbourhood variation in the incidence of psychotic disorders in Southeast London |
Q38861349 | Prevalence, impact and cultural context of psychotic experiences among ethnic minority youth |
Q34953640 | Safety assessment of the pyridoindole derivative SMe1EC2: developmental neurotoxicity study in rats |
Q33932520 | Schizophrenia: current concepts and approaches to patient care |
Q35797941 | The Danish High Risk and Resilience Study--VIA 7--a cohort study of 520 7-year-old children born of parents diagnosed with either schizophrenia, bipolar disorder or neither of these two mental disorders |
Q30501563 | The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development |
Q51750311 | The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. |
Q34659000 | The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia. |
Q28303485 | The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? |
Q30470162 | The nuclear factor-κB inhibitor pyrrolidine dithiocarbamate reduces polyinosinic-polycytidilic acid-induced immune response in pregnant rats and the behavioral defects of their adult offspring |
Q39927000 | The role of vulnerability factors in individuals with an at-risk mental state of psychosis |
Q37022580 | Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention |
Q35865658 | Wellbeing and resilience: mechanisms of transmission of health and risk in parents with complex mental health problems and their offspring--The WARM Study |